SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-22-000582
Filing Date
2022-05-13
Accepted
2022-05-13 16:53:41
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q opgen_10q-033122.htm   iXBRL 10-Q 771326
2 EXHIBIT 31.1 ex31x1.htm EX-31 7492
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 7732
4 EXHIBIT 32 ex321.htm EX-32.1 4578
  Complete submission text file 0001079973-22-000582.txt   5927956

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE opgn-20220331.xsd EX-101.SCH 76852
6 XBRL CALCULATION FILE opgn-20220331_cal.xml EX-101.CAL 55813
7 XBRL DEFINITION FILE opgn-20220331_def.xml EX-101.DEF 339545
8 XBRL LABEL FILE opgn-20220331_lab.xml EX-101.LAB 651891
9 XBRL PRESENTATION FILE opgn-20220331_pre.xml EX-101.PRE 343770
60 EXTRACTED XBRL INSTANCE DOCUMENT opgen_10q-033122_htm.xml XML 709876
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37367 | Film No.: 22923656
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences